These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 798204)

  • 1. Antagonists, inhibitors and antisera in the evaluation of vascular renin activity. The role of local generation of angiotensin II.
    Swales JD
    Prog Biochem Pharmacol; 1976; 12():98-113. PubMed ID: 798204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a nonpeptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibody.
    Wong PC; Price WA; Reilly TM; Duncia JV; Timmermans PB
    J Pharmacol Exp Ther; 1989 Aug; 250(2):515-22. PubMed ID: 2668502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular angiotensin receptors and their role in blood pressure control.
    Thurston H
    Am J Med; 1976 Nov; 61(5):768-78. PubMed ID: 185902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
    Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial wall renin.
    Swales JD; Abramovici A; Beck F; Bing RF; Loudon M; Thurston H
    J Hypertens Suppl; 1983 Oct; 1(1):17-22. PubMed ID: 6400106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
    Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y
    Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular actions of angiotensin in the fowl (Gallus domesticus). II. Angiotensin analog agonists and antagonists.
    Moore AF; Strong JH; Buckley JP
    Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):447-57. PubMed ID: 6267670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II is concentrated or locally produced in rat adrenal gland.
    Mendelsohn FA
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():3-7. PubMed ID: 6958399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the renin-system in normo- and hypertension. Effect of angiotensin-inhibitor (1-sar-8-ala-angiotensin II) on the blood pressure of conscious or anaesthetized normal, nephrectomized and renal hypertensive rats.
    Bing J; Nielsen K
    Acta Pathol Microbiol Scand A; 1973 May; 81(3):254-62. PubMed ID: 4358386
    [No Abstract]   [Full Text] [Related]  

  • 11. The pathophysiology of renovascular hypertension.
    Robertson JI; Morton JJ; Tillman DM; Lever AF
    J Hypertens Suppl; 1986 Oct; 4(4):S95-103. PubMed ID: 3534187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of angiotensin antagonists in various forms of experimental arterial hypertension.
    Ferrario CM; Bumpus FM; Masaki Z; Khosla MC; McCubbin JW
    Prog Biochem Pharmacol; 1976; 12():86-97. PubMed ID: 1019172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in responses to bradykinin, angiotensin I, and angiotensin II during the induction phase of one-kidney, one-wrapped hypertension and associated arterial disease in rabbits.
    Campbell WG; Donohue JA; Duket LH
    Am J Pathol; 1980 Feb; 98(2):457-84. PubMed ID: 6243872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volume control and altered renal and adrenal responsiveness to angiotensin in essential hypertension: implications for treatment with converting enzyme inhibition.
    Hollenberg NK; Williams GH
    J Hypertens Suppl; 1983 Oct; 1(1):119-28. PubMed ID: 6100600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular renin-like activity and blood pressure.
    Basso N; Kurnjek ML; Taquini AC
    Mayo Clin Proc; 1977 Jul; 52(7):437-41. PubMed ID: 875467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
    Tarpey SB; Bennett T; Randall MD; Gardiner SM
    Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic factors involved in renovascular hypertension. State of the art.
    Bumpus FM; Khosla MC
    Mayo Clin Proc; 1977 Jul; 52(7):417-23. PubMed ID: 327161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of angiotensin antagonists and antiserum upon the pressor response to renin: further evidence for the local generation of angiotensin II.
    Thurston H; Swales JD
    Clin Sci Mol Med; 1974 Feb; 46(2):273-6. PubMed ID: 4361487
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular effects of microinjection of angiotensin II in the brainstem of renal hypertensive rats.
    Mosqueda-Garcia R; Tseng CJ; Appalsamy M; Robertson D
    J Pharmacol Exp Ther; 1990 Oct; 255(1):374-81. PubMed ID: 2213569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the functional antagonism and antihypertensive activity displayed by a monoclonal antibody to angiotensin II.
    Reilly TM; Wong PC; Price WA; Timmermans PB
    J Pharmacol Exp Ther; 1988 Jan; 244(1):160-5. PubMed ID: 3275771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.